RXO investors back directors, auditor and pay
RXO, Inc. reported results from its 2026 Annual Meeting of Stockholders held on May 12, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RXO, Inc. reported results from its 2026 Annual Meeting of Stockholders held on May 12, 2026. Stockholders elected eight directors for terms running until the 2027 annual meeting, with support levels generally around 148–149 million votes in favor for most nominees.
They ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 154,953,800 votes for and minimal opposition. Stockholders also approved an amendment to the 2022 Omnibus Incentive Compensation Plan to increase available shares, and supported executive compensation in a nonbinding advisory vote, with 142,771,274 votes in favor.
8-K Event Classification
Key Figures
Key Terms
broker non-votes financial
independent registered public accounting firm financial
Omnibus Incentive Compensation Plan financial
nonbinding, advisory resolution financial
emerging growth company regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did RXO (RXO) stockholders decide at the 2026 annual meeting?
Which directors were elected at RXO (RXO)’s 2026 annual meeting and with how many votes?
Did RXO (RXO) stockholders ratify Deloitte & Touche as the company’s auditor?
What change was approved to the RXO (RXO) 2022 Omnibus Incentive Compensation Plan?
How did RXO (RXO) stockholders vote on executive compensation in 2026?
When and where was the RXO (RXO) 2026 Annual Meeting of Stockholders held?
AI-generated analysis. How Rhea-AI works. Not financial advice.